Lowe's, Target Miss...
Health Care: Drugs
Albany Molecular Research Inc. (AMRI: NASDAQ)
$11.04 0.13 | 1.19%
05/22/13 - 10:48 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -3.78M | -32.30M | -62.87M | -16.70M |
| Operating Gains/Losses | 176.00K | 83.00K | 331.00K | 753.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -13.57M | 2.73M | -7.98M | 14.75M |
| (Increase) Decrease in Inventories | -2.21M | 215.00K | -1.34M | -1.06M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 196.00K | -11.95M | 15.51M | -4.20M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | -355.00K | -8.74M | -2.10M |
| (Increase) Decrease In Other Working Capital | 1.94M | -4.98M | -1.20M | 10.85M |
| Other Non-Cash Items | 10.42M | 24.11M | 51.21M | 29.58M |
| Net Cash From Continuing Operations | 15.34M | -1.48M | -1.32M | 39.09M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 15.34M | -1.48M | -1.32M | 39.09M |
| Sale of Property, Plant & Equipment | 447.00K | 0.00 | 0.00 | 143.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 16.19M |
| Purchases of Property, Plant & Equipment | -10.44M | -11.26M | -12.65M | -15.86M |
| Acquisitions | 0.00 | 0.00 | -46.34M | -12.00K |
| Purchases of Short-Term Investments | 0.00 | -817.00K | -7.82M | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -9.78M | 3.97M | -45.06M | -19.09M |
| Issuance of Debt | 5.00M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 531.00K | 671.00K | 0.00 | 5.00K |
| Repayment of Long-Term Debt | -2.84M | -7.37M | -270.00K | -260.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | -10.00M | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -5.23M | -270.00K | 592.00K | 510.00K |
| Net Cash From Financing Activities | -2.53M | -6.97M | -9.68M | 255.00K |
| Effect of Exchange Rate Changes | 288.00K | -1.28M | 850.00K | 304.00K |
| Net Change in Cash & Cash Equivalents | 3.31M | -5.76M | -55.21M | 20.55M |
Portfolios with AMRI
- Portfolio NameUser Type
- UserJoePa66
- UserPART 7 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserPART 7 JPMorgan 26th Annual...
- Userwafessler Portfolio 1
- UserSUPRATRADE SMALL CAP "...
- Userscorp Portfolio 1
- UserNew IDea
- Userctshagr Portfolio 1
- Useraaron81483 Portfolio 1
Latest AMRI Headlines from TheStreet
- Albany Molecular Research Inc. Stock Upgraded (AMRI) 09.26.12 | 05:09 am
- Stocks Under $5: Hidden Value in Healthcare
09.01.11 | 05:09 am - Applespeed Fund Goes Bargain Hunting 10.30.10 | 06:10 am
- Albany Molecular Files Allegra Patent Lawsuits 09.15.09 | 10:09 am
- Movers Roundup: Urban Outfitters, Hot Topic 05.07.09 | 02:05 pm
- Albany Molecular Shares Fall On 1Q Profit, Outlook 05.07.09 | 11:05 am
- Health Winners & Losers: Onyx 08.06.08 | 05:08 pm
- Monday's Winners & Losers: Yahoo! 05.05.08 | 04:05 pm
- Monday's Health Winners & Losers 05.05.08 | 02:05 pm
- Monday's Health Winners & Losers 02.11.08 | 04:02 pm
Press Releases for AMRI
- AMRI CFO To Present At The UBS Global Healthcare Conference - PR Newswire 05.15.13 | 08:05 am
- AMRI To Announce First Quarter Results - PR Newswire 04.24.13 | 08:04 am
- AMRI And Ono Broaden SMARTSOURCINGâ¿¢ Collaboration - PR Newswire 04.23.13 | 03:04 pm
- AMRI CEO To Present At The 12th Annual Needham Healthcare Conference - PR Newswire 04.23.13 | 08:04 am
- AMRI Promotes Takeshi Yura, Ph.D., To Vice President Of Discovery And Development Services, Asia - PR Newswire 02.25.13 | 08:02 am
- AMRI And Codexis Announce Technology Collaboration - PR Newswire 02.13.13 | 08:02 am
- AMRI Signs Agreement For Exclusive License Of Its Tubulin Inhibitor Program For Cancer - PR Newswire 02.11.13 | 08:02 am
- AMRI To Announce Fourth Quarter Results - PR Newswire 01.15.13 | 08:01 am
- AMRI Promotes Richard A. Saffee To Vice President And General Manager Of Large Scale Manufacturing - PR Newswire 01.08.13 | 08:01 am
- AMRI Extends Long Term Supply Relationship With GE Healthcare - PR Newswire 12.06.12 | 08:12 am
Partner Headlines for AMRI
- 5 Undervalued Healthcare Stocks That Analysts Love - Seeking Alpha 08.29.12 | 09:08 am
- Pre-Market Earnings Report for August 1, 2012 : AMT, ADP, AGN, AVP, GAS, AGP, BOKF, BAH, BCPC, ASCA, AMRI, ALVR - NASDAQ 07.31.12 | 08:07 pm
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 11.14.11 | 09:11 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 11.10.11 | 09:11 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.12.10 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 10.05.10 | 09:10 am
- UPDATE 1-Albany Molecular says facility gets warning letter - Reuters 08.20.10 | 06:08 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.06.10 | 09:08 am
